BMAL1 and head and neck squamous cell carcinoma: Surprisingly, at levels closer to physiological doses (10 nM and 100 μM), melatonin does not resynchronize Bmal1, thus suggesting that low levels of melatonin have no effect on cancer clock genes in HNSCC cells.